Dade Behring Holdings Inc.

Mr. Quinn was appointed Executive Vice President of Dade Behring Holdings, Inc. in December 2002. Mr. Quinn is the Chief Operating Officer of Dade Behring Inc., a position to which he was appointed in January 2007. He is responsible for global sales, service, marketing, reagent and consumable manufacturing and logistics. Mr. Quinn joined us in July 1998 as Dade Behring Inc. Group President, Biology and became President, EMA in March 1999, responsible for all commercial operations within Europe, the Middle East and Africa. In October 2000, he was promoted to President, International, responsible for all commercial operations outside of the U.S. and Canada. In January of 2002, he was promoted to President, Global Customer Management. Prior to joining us in 1998, Mr. Quinn worked as Global President, Hospital Business, for Mallinckrodt Medical, based in Hennef (Germany), a medical device company. Prior to joining Mallinckrodt Medical in 1982, Mr. Quinn was Controller for Abbott Laboratories operations in Ireland. Mr. Quinn earned a Bachelor of Science degree in economics from Cork University in Ireland in 1976. He continued his studies to become a Chartered Management Accountant, and was subsequently awarded a fellowship of the Institute of Chartered Management Accountants (F.C.M.A.).

Mr. Duffey was appointed Chief Financial Officer of Dade Behring Holdings, Inc. in September 2001 and is responsible for finance and investor relations. Mr. Duffey joined us in 1995 as Dade Behring Inc. Vice President, Tax. In January 1997, Mr. Duffey was promoted to Corporate Vice President, Financial Services, having responsibility for Shared Services, Tax and Internal Audit. In May 1999, he was promoted to Corporate Vice President and Controller and became Senior Vice President and Controller in January 2001. Prior to joining us in 1995, Mr. Duffey worked for the Chicago office of Price Waterhouse. Mr. Duffey s thirteen years at Price Waterhouse included a tour-of-duty in the firm s Washington D.C. National Office in the Accounting Methods Group. Mr. Duffey is a Certified Public Accountant and holds a B.A. in Accounting from Michigan State University.

Beverly A. Huss was appointed as a director on July 28, 2005 and is a member of the Compensation and Governance Committees. Ms. Huss has been President and Chief Executive Officer of Exploramed NC3, an early stage medical device company since January 2007. Prior to that Ms. Huss had been employed by Guidant Corporation, a manufacturer of surgical and medical instruments where she had held positions of increasing responsibility since 1986 and most recently was President of the Endovascular Solutions division. Ms Huss was an engineer with Honeywell Inc. from 1984 to 1986 and with Jones and Laughlin Steel, Inc. from 1982 to 1984. Ms. Huss is a director of publicly-held Wright Medical Technology, Inc., a designer, manufacturer and distributor of orthopedic implant devices. Ms. Huss is Chairman of the Board of the Santa Clara County (California) chapter of the American Heart Association. Ms. Huss holds an M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois.

Jeffrey D. Benjamin became one of our directors in October 2005 and was previously one of our directors from August 1998 through July 2003 and a director of our parent holding company from July 2003 through its merger into us. Mr. Benjamin has been a Senior Advisor to Apollo Management, LP since September 2002. He had previously been a Managing Director of Libra Securities LLC, an investment banking firm, from January 2002 to September 2002 and served as Co-Chief Executive Officer of Libra Securities from January 1999 to December 2001. Mr. Benjamin is also a director of Dade Behring Holdings Inc., NTL Incorporated and Goodman Global, Inc.

N. Leigh Anderson, Ph.D ., has served as a member of our board of directors since March 2006 and is a member of our audit committee and compensation committee. Since 2002, Dr. Anderson has served as the Chief Executive Officer of the Plasma Proteome Institute, a scientific research institute in Washington, D.C., of which he is also a founder. Dr. Anderson also consults through Anderson Forschung Group, of which he has been a Principal since 2002 and a member of its board of directors since 2004. From 2001 to 2002, Dr. Anderson served as the Chief Scientific Officer and a member of the board of directors of Large Scale Biology Corporation, a biotechnology company that previously traded on NASDAQ under the symbol LSBC. Dr. Anderson also served as a member of the board of directors and a member of the audit committee of Dade Behring Holdings, Inc. (DADE), a NASDAQ-listed company, from 2002 until its acquisition by Siemens AG in 2007. Dr. Anderson earned a B.A. in Physics from Yale University and a Ph.D. in Molecular Biology from Cambridge University.

Sam Skinner was appointed White House Chief of Staff by President George W Bush after holding the position of Secretary of the Department of Transportation. Mr Skinner was President of the Commonwealth Edison Company and its holding company Unicom Corporation, one of the largest electric utilities in the US. He was then Chairman, President and CEO of USF Corporation a leading transportation and logistics company before retiring in May 2003. Mr Skinner has more than 20 years experience in the legal profession, part of which he served in the office of the US Attorney for the Northern District of Illinois and as US Attorney. While practicing law he also served as Chairman of the Regional Transportation Authority of north-eastern Illinois, the second largest mass transportation district in the US. He is a former member of the BHP Limited North American Advisory Board. Mr Skinner currently consults on complex litigation matters, government matters, transportation issues and corporate governance. He is a graduate of the University of Illinois and the DePaul University Law School.

Edward Murphy is a member of the Board of Managers of The Egg Factory. Dr. Murphy is President and Chief Executive Officer of Carilion Health System. Prior to joining Carilion Health System and beginning in 1994, he was President and Chief Executive Officer of Seton Health System in Troy, New York. Dr. Murphy's accomplishments include negotiation of a single healthcare delivery system from the components of two separate organizations, development and founding of an integrated delivery system providing service to six counties in Upstate New York and was Vice President of Clinical Services at Leonard Hospital from 1989-1991. He also served as President and Chief Executive Officer at Leonard Hospital from 1991 until the 1994 merger of Leonard Hospital and St. Mary's Hospital to form Seton Health System. Dr. Murphy's undergraduate studies were at the University of Albany and he obtained his medical degree from Harvard University, graduating cum laude. Dr. Murphy has served as a clinical professor at the University of Albany School of Public Health, and Adjunct Assistant Professor at Rensselaer Polytechnic Institute, School of Management. Dr. Murphy has served on the Boards of Directors of the Upstate Physician Network, the New York State Hospital Review and Planning Council and the Troy Redevelopment Fund. He is presently on the Boards of Directors of HANYS Insurance Company & Trust, United Way of Roanoke Valley, Make-A-Wish Foundation of Richmond and Western Virginia, Hollins University, Center in the Square of Western Virginia Foundation for the Arts and Sciences, Virginia FREE and the Statewide Virginia Chamber of Commerce. Mark Murphy is a Manager of The Egg Factory, LLC. Mr. Murphy served as President of Supply Chain Services, a division of Johnson and Johnson Health Care Systems, Inc., which had sales of $4 billion and a staff of 450. He was also President, Johnson and Johnson Hospital Services, Inc., which had sales of $2 billion and a staff of 850. He is currently a business consultant for Johnson and Johnson working with Innotech, Inc. Mr. Murphy serves on the board of managers of Hearing Enhancement Company, LLC, and has previously served on the board of directors of the University of Tampa and Compton Plant Meade Hospital.

Richard W. Roedel (59). Mr. Roedel spent much of his career with BDO Seidman LLP, an international accounting and consulting firm, where he ultimately served as Chairman and Chief Executive Officer. Mr Roedel currently serves as director of Brightpoint, Inc., IHS Inc., Sealy Corporation, Lorillard, Inc. and Luna Innovations Incorporated. Mr Roedel is chairman of the audit committees of Brightpoint, Sealy, Lorillard, Inc. and Luna Innovations Incorporated. Mr Roedel is also a board member of the Association of Audit Committee Members, Inc., a not-for-profit organization dedicated to strengthening audit committees. Mr. Roedel was on the board and chairman of the audit committee of Dade Behring Holdings, Inc. from October 2002 until November 2007 when Dade was acquired by Siemens AG. Mr. Roedel served in various capacities at Take-Two Interactive Software, Inc. from 2002 until 2005, including Chairman and Chief Executive Officer. From 1971 through 2000, he was employed by BDO Seidman LLP, becoming an audit partner in 1980, later being promoted in 1990 to Managing Partner in Chicago and then Managing Partner in New York in 1994 and finally in 1999 to Chairman and Chief Executive Officer. Mr Roedel is a graduate of The Ohio State University and a C.P.A.